Methods and measures: What's new for MS?

Multiple Sclerosis Journal

Volumn 19, Issue 6, 2013, Pages 709-713

  Mayo, Nancy E ^a,b   Hum, Stanley ^a   Kuspinar, Ayse ^a  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

fatigue; Multiple sclerosis; outcome measurement; quality of life

Indexed keywords

CLINICAL DECISION MAKING; DEPRESSION; DISEASE COURSE; FATIGUE; HUMAN; MATHEMATICAL ANALYSIS; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PAIN; QUESTIONNAIRE; RASCH MEASUREMENT THEORY; REVIEW; COST OF ILLNESS; DECISION SUPPORT SYSTEM; DISABILITY; HEALTH STATUS; HEALTH STATUS INDICATOR; MENTAL HEALTH; PATHOPHYSIOLOGY; PATIENT; PREDICTIVE VALUE; PROGNOSIS; PSYCHOLOGY; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

COST OF ILLNESS; DECISION SUPPORT TECHNIQUES; DISABILITY EVALUATION; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; MENTAL HEALTH; MULTIPLE SCLEROSIS; PATIENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84877622664     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512470311     Document Type: Review

References (34)

1. Fox EJ, Rhoades RW. New treatments and treatment goals for patients with relapsing-remitting multiple sclerosis. Curr Opin Neurol. 2012 ; 25: S11 - S19
2. Asano M, Dawes D, Arafah A, et al. What does a structured review of the effectiveness of exercise interventions for persons with multiple sclerosis tell us about the challenges of designing trials?. Mult Scler. 2009 ; 15: 412-421
3. Guidance for industry on patient-reported outcome measures - Use in medical product development to support labeling claims. Fed Regist. 2009 ; 74: 65132-65133
4. Berzon RA Quality of life assessment in clinical trials: Methods and practice. Staquet MJ Hays RD Fayers PM, ed. New York: Oxford University Press ; 1998: 3-15.
5. Doward LC, Gnanasakthy A, Baker MG. Patient reported outcomes: Looking beyond the label claim. Health Qual Life Outcomes. 2010 ; 8: 89
6. Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA. 1994 ; 272: 619-626
7. Guyatt GH, Cook DJ. Health status, quality of life, and the individual. JAMA. 1994 ; 272: 630-631
8. Flanagan JC. Measurement of quality of life: Current state of the art. Arch Phys Med Rehabil. 1982 ; 63: 56-59
9. Magasi S, Ryan G, Revicki D, et al. Content validity of patient-reported outcome measures: Perspectives from a PROMIS meeting. Qual Life Res. 2012 ; 21: 739-746
10. Farnik M, Pierzchala WA. Instrument development and evaluation for patient-related outcomes assessments. Patient Relat Outcome Meas. 2012 ; 3: 1-7
11. Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med. 1999 ; 48: 1531-1548
12. Wilson IB. Clinical understanding and clinical implications of response shift. Soc Sci Med. 1999 ; 48: 1577-1588
13. Barclay-Goddard R, Lix LM, Tate R, et al. Health-related quality of life after stroke: Does response shift occur in self-perceived physical function?. Arch Phys Med Rehabil. 2011 ; 92: 1762-1769
14. Barsevick AM, Cleeland CS, Manning DC, et al. ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage. 2010 ; 39: 1086-1099
15. Krupp LB, Serafin DJ, Christodoulou C. Multiple sclerosis-associated fatigue. Expert Rev Neurother. 2010 ; 10: 1437-1447
16. Andrich D, de Jong JHAL, Sheridan BE Applications of latent trait and latent class models in the social sciences. Rost J Langeheine R, ed. New York: Waxmann ; 1997: 59-70.
17. Andrich D. Rating scales and Rasch measurement. Expert Rev Pharmacoecon Outcomes Res. 2011 ; 11: 571-585
18. Tennant A, McKenna SP, Hagell P. Application of Rasch analysis in the development and application of quality of life instruments. Value Health. 2004 ; 7: S22 - S26
19. Tesio L. Measuring behaviours and perceptions: Rasch analysis as a tool for rehabilitation research. J Rehabil Med. 2003 ; 35: 105-115
20. Andrich D Rasch models for measurement. Newbury Park: Sage Publications ; 1988 :
21. Tesio L, Perucca L, Franchignoni FP, et al. A short measure of balance in multiple sclerosis: Validation through Rasch analysis. Funct Neurol. 1997 ; 12: 255-265
22. van der Linden FA, Kragt JJ, Hobart JC, et al. Proxy measurements in multiple sclerosis: Agreement between patients and their partners on the impact of multiple sclerosis in daily life. J Neurol Neurosurg Psychiatry. 2006 ; 77: 1157-1162
23. Young C, Mills R, Woolmore J, et al. The unidimensional self-efficacy scale for MS (USE-MS): Developing a patient based and patient reported outcome. Mult Scler. 2012 ; 18: 1326-1333
24. Hobart JC, Riazi A, Thompson AJ, et al. Getting the measure of spasticity in multiple sclerosis: The Multiple Sclerosis Spasticity Scale (MSSS-88). Brain. 2006 ; 129: 224-234
25. Hobart J, Cano S. Improving the evaluation of therapeutic interventions in multiple sclerosis: The role of new psychometric methods. Health Technol Assess. 2009 ; 13: iii ix 177 - iii
26. Cano SJ, Barrett LE, Zajicek JP, et al. Beyond the reach of traditional analyses: Using Rasch to evaluate the DASH in people with multiple sclerosis. Mult Scler. 2011 ; 17: 214-222
27. Kieseier BC, Stüve O. A critical appraisal of treatment decisions in multiple sclerosis - old versus new. Nat Rev Neurol. 2011 ; 7: 255-262
28. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology. 1983 ; 33: 1444-1452
29. Kurtzke JF. A new scale for evaluating disability in multiple sclerosis. Neurology. 1955 ; 5: 580-583
30. Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Dis. 1987 ; 40: 593-603
31. Rand-Hendriksen K, Augestad LA, Kristiansen IS, et al. Comparison of hypothetical and experienced EQ-5D valuations: Relative weights of the five dimensions. Qual Life Res. 2012 ; 21: 1005-1012
32. Poissant L, Mayo NE, Wood-Dauphinee S, et al. The development and preliminary validation of a Preference-Based Stroke Index (PBSI). Health Qual Life Outcomes. 2003 ; 1: 43
33. Brazier J, Ratcliffe J, Salomon JA, et al Measuring and valuing health benefits for economic evaluation. New York: Oxford University Press Inc ; 2007 :
34. Young T, Yang Y, Brazier JE, et al. The first stage of developing preference-based measures: Constructing a health-state classification using Rasch analysis. Qual Life Res. 2009 ; 18: 253-265